Aller au contenu

← Journal/21 July 2026·6 min de lecture

CBD and libido: what the research really says, and what it does not

Par ·

To date, no controlled study has tested cannabidiol (CBD) on libido or human sexual function. The 2020 reference review confirms it: CBD has "not been tested empirically" on sexual behaviour. The positive data doing the rounds concern whole cannabis or THC, through self-reported surveys, not isolated CBD. Here is the real state of the research, study by study, with no promises.

CBD and libido: what the research really says, and what it does not

Has CBD ever been tested on libido?

Let us start with the gap, because it sits at the heart of the subject. The reference review published in Sexual Medicine Reviews in 2020 states that CBD has "not been tested empirically" as regards its effect on sexual behaviour, neither in animals nor in humans. No randomised, double-blind, placebo-controlled trial has measured CBD on libido.

That absence is the single most important fact in this entire article. Any assertion presenting CBD as a stimulant of desire therefore advances without direct evidence. A product page promising an "aphrodisiac" effect is extrapolating: it cites nothing solid, for a simple reason. Nothing solid yet exists on this particular molecule.

The endocannabinoid system and the sexual response

The endocannabinoid system does take part in sexual physiology, but in a counter-intuitive way that complicates any shortcut. A study published in the Journal of Sexual Medicine in 2012 observed, in women, that physiological and subjective arousal was accompanied by a significant drop in circulating endocannabinoids, anandamide and 2-AG, which then rose again after orgasm.

That result shows involvement, not benefit. It does not say that raising cannabinoid levels improves the sexual response: the observation would rather point the other way. The system is there, active, but the way it works is anything but linear. This is precisely the nuance that marketing erases when it turns "involved" into "beneficial".

The positive effects reported concern THC, not CBD

Almost all the favourable feedback relates to whole cannabis, rich in THC, never to isolated CBD. A survey published in the Journal of Cannabis Research in 2023, conducted among some 800 adults, links cannabis use with increased desire and orgasm intensity. But the participants were using THC cannabis, and the data were retrospective and self-reported.

Transposing that result to CBD would be a methodological error. CBD and THC share neither the same mechanism nor the same effects. The confusion often comes from the idea of an entourage effect, according to which the plant's compounds would act together. It is an interesting avenue, but it remains a hypothesis, as we explain on the subject of the CBD entourage effect.

What do the scientific reviews conclude?

They conclude with an acknowledged uncertainty, not an established effect. That same 2020 review sums up the entire human evidence base as twelve studies: eleven retrospective surveys and a single prospective cohort. Its conclusion deserves to be quoted as it stands. An effect "appears to exist" in animals as in humans, "but whether it is positive or negative depending on dose and species requires further study".

In other words, the research does not even know in which direction the effect would go. Twelve studies, eleven of them mere recall surveys: that is little, and it is fragile. No shop argument should lean on that to talk about desire.

Dose, one more blind spot

The 2020 review stresses that the effect could vary with dose, without anyone knowing in which direction. No "for libido" range therefore rests on data: it would be invented from scratch. This is a complete blind spot, not a fine adjustment still waiting to be discovered.

If you already use CBD for other reasons, it is better to reason in general usage markers than in a targeted promise. We gather those markers in our guide on how much CBD to take. And judging your own experience honestly takes time: see when to start assessing the effects of CBD.

Should you expect an effect of CBD on libido?

Given the current state of knowledge, no: you should expect nothing specific from it. The only plausible account is indirect. By modulating anxiety, CBD could play a part in situations where nervous tension gets in the way. But no study has demonstrated that chain in humans. It is a working hypothesis, not a result.

For overall well-being, on which intimate life also depends, the documented levers remain the safest: sleep, physical activity, stress management. We bring them together in our seven-pillar wellness routine. And if a difficulty settles in, the right place to turn is a healthcare professional, never a product page.

Frequently asked questions

Does CBD have a proven effect on libido?

No. No controlled study has tested CBD on human sexual function. The favourable feedback in circulation concerns whole cannabis or THC, collected through self-reported surveys. As things stand, no effect of CBD on libido is demonstrated, in either direction.

Is CBD an aphrodisiac?

No data allows that to be claimed. The word "aphrodisiac" belongs to marketing, not to science: no clinical trial validates it for CBD. In France, a CBD product may not claim any effect of that kind in any case. Stay cautious in the face of shop promises.

Do THC and CBD have the same effects on sexuality?

No. The positive surveys concern THC, the psychotropic molecule of cannabis, not CBD. The two compounds have distinct mechanisms. Attributing to CBD results obtained with THC is a frequent methodological error, often sustained by sales arguments.

Does the endocannabinoid system play a role in desire?

Yes, it takes part, but in a complex way. A 2012 study observed that arousal was accompanied by a drop in circulating endocannabinoids, which rose again after orgasm. That involvement does not mean that adding cannabinoids improves the sexual response: the observation rather suggests the opposite.

Can you find "special libido" CBD in France?

Labels of that kind do appear, but no claim of an effect on desire is authorised for a CBD product in France. Such positioning is therefore a commercial argument, not a validated indication. The composition of a "libido CBD" remains that of an ordinary CBD.


Written by the Phytogrammes team

Every article in this journal draws on primary sources (ANSM, EFSA, EUR-Lex, peer-reviewed publications) and on the lab's own practice: batch-by-batch HPLC analyses, measured cannabinoid profiles. Our approach.

Article published on . CBD is not a medicine.

Phytogrammes products that pair well